California biotech Kali Therapeutics has snagged its first major pharma partner, Sanofi, which is committing $180 million in near-term payments for rights to a T-cell engager (TCE) for autoimmune ...
It’s fair to say that the topic of so-called ‘AI coding assistants’ is somewhat controversial. With arguments against them ...
To be Colorado’s most trusted source for information that educates, entertains and inspires our readers for the betterment of our community. Ethics Policy Policy on sources Verification and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results